{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:23:40Z","timestamp":1787775820703,"version":"build-2784847793"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>Cachexia is one of the major chemotherapy-induced adverse effects, characterized by gradual depletion of muscle mass. Currently, there is no specific treatment for cachexia. This study aims to evaluate the role of silymarin in attenuating muscle wasting in a model of cisplatin-induced cachexia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>\n                      Female Swiss albino mice were divided into three groups (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 6) and received the treatment according to their group for 7 days: NC (Normal Control, receiving normal saline), CP (Cisplatin, receiving cisplatin 3 mg\/kg i.p.) and SY+CP (Silymarin+Cisplatin, receiving silymarin 100 mg\/kg orally two hours before cisplatin 3mg\/kg i.p). Body weight, muscle weight, tumor necrosis factor alpha (TNF-\u03b1), and GSH levels were measured, and muscle histopathological studies were performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Silymarin prevented cisplatin-induced damage in the triceps, quadriceps, and gastrocnemius muscles. Cisplatin administration altered tissue architecture and decreased the size and cross-sectional area of all three muscle fibers, which were significantly restored in the silymarin-treated group. Muscle tissue homogenates from the silymarin-treated group exhibited higher levels of reduced glutathione compared to the cisplatin group. The elevated serum TNF-\u03b1 levels in the cisplatin group were decreased from 183 \u00b1 1.66 pg\/mL to 117.40 \u00b1 10.47 pg\/mL in the silymarin-treated mice. Tripartite motif-containing 63 (TRIM63), a muscle atrophy marker, was upregulated, and myogenin, a marker of myogenesis, was decreased by cisplatin, and the expression of both markers was reversed upon silymarin treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Silymarin attenuates cisplatin-induced cachexia through TRIM63 suppression, myogenin restoration, and reduced oxidative and inflammatory stress.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijp.ijp_136_25","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T07:00:10Z","timestamp":1772434810000},"page":"101-108","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Silymarin alleviates cisplatin-induced cachexia via modulating tripartite motif containing 63 (TRIM63) and myogenin"],"prefix":"10.4103","volume":"58","author":[{"given":"Shreya","family":"Das","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology and Science, Pilani, Pilani Campus, Vidya Vihar, Pilani, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Jyotika","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology and Science, Pilani, Pilani Campus, Vidya Vihar, Pilani, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Pahuja","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology and Science, Pilani, Pilani Campus, Vidya Vihar, Pilani, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapana","family":"Kushwaha","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli (NIPER-R),Bijnor-Sisendi Road, Sarojini Nagar, Near CRPF Base Camp, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Shrivastava","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology and Science, Pilani, Pilani Campus, Vidya Vihar, Pilani, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"R1-20260302","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3390\/ijms21041242","article-title":"Cisplatin-induced skeletal muscle dysfunction:Mechanisms and counteracting therapeutic strategies","volume":"21","author":"Conte","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R2-20260302","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jcsm.12360","article-title":"Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism","volume":"10","author":"Pin","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R3-20260302","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.3390\/ijms21207724","article-title":"Effect of silymarin supplementation on physical performance, muscle and myocardium histological changes, bodyweight, and food consumption in rats subjected to regular exercise training","volume":"21","author":"Vargas-Mendoza","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R4-20260302","doi-asserted-by":"crossref","first-page":"5694223","DOI":"10.1155\/2022\/5694223","article-title":"Silibinin alleviates muscle atrophy caused by oxidative stress induced by cisplatin through ERK\/FoxO and JNK\/FoxO pathways","author":"Chi","year":"2022","journal-title":"Oxid Med Cell Longev 2022"},{"key":"R5-20260302","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/nu13010049","article-title":"Identification of Withania somnifera-Silybum marianum-Trigonella foenum-graecum formulation as a nutritional supplement to contrast muscle atrophy and sarcopenia","volume":"13","author":"Salvadori","year":"2020","journal-title":"Nutrients"},{"key":"R6-20260302","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.ajpath.2022.09.003","article-title":"Forkhead box O signaling pathway in skeletal muscle atrophy","volume":"192","author":"Chen","year":"2022","journal-title":"Am J Pathol"},{"key":"R7-20260302","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13395-021-00260-x","article-title":"Dynamics of myogenic differentiation using a novel myogenin knock-in reporter mouse","volume":"11","author":"Benavente-Diaz","year":"2021","journal-title":"Skelet Muscle"},{"key":"R8-20260302","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11010-020-03849-w","article-title":"Natural flavonoid silibinin promotes the migration and myogenic differentiation of murine C2C12 myoblasts via modulation of ROS generation and down-regulation of estrogen receptor \u03b1 expression","volume":"474","author":"Long","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"R9-20260302","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1083-8791(03)00087-9","article-title":"Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses","volume":"9","author":"Korngold","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"R10-20260302","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.3390\/ijms24087585","article-title":"Cisplatin in ovarian cancer treatment-known limitations in therapy force new solutions","volume":"24","author":"Zo\u0144","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R11-20260302","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jcsm.13120","article-title":"Capsaicin alleviates cisplatin-induced muscle loss and atrophy in vitro and in vivo","volume":"14","author":"Huang","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R12-20260302","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/jcsm.13035","article-title":"PGC1\u03b1 overexpression preserves muscle mass and function in cisplatin-induced cachexia","volume":"13","author":"Huot","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R13-20260302","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fimmu.2020.00077","article-title":"Magnolol attenuates cisplatin-induced muscle wasting by M2c macrophage activation","volume":"11","author":"Lee","year":"2020","journal-title":"Front Immunol"},{"key":"R14-20260302","doi-asserted-by":"crossref","first-page":"101398","DOI":"10.1016\/j.tranon.2022.101398","article-title":"PLAG alleviates cisplatin-induced cachexia in lung cancer implanted mice","volume":"20","author":"Kim","year":"2022","journal-title":"Transl Oncol"},{"key":"R15-20260302","doi-asserted-by":"crossref","first-page":"100255","DOI":"10.1016\/j.aohep.2020.08.072","article-title":"Silymarin is an ally against insulin resistance:A review","volume":"23","author":"MacDonald-Ramos","year":"2021","journal-title":"Ann Hepatol"},{"key":"R16-20260302","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4142\/jvs.2014.15.1.51","article-title":"Protective effects of silymarin on fumonisin B1-induced hepatotoxicity in mice","volume":"15","author":"Sozmen","year":"2014","journal-title":"J Vet Sci"},{"key":"R17-20260302","doi-asserted-by":"crossref","first-page":"e0191353","DOI":"10.1371\/journal.pone.0191353","article-title":"Silymarin prevents acetaminophen-induced hepatotoxicity in mice","volume":"13","author":"Papackova","year":"2018","journal-title":"PLoS One"},{"key":"R18-20260302","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13395-023-00323-1","article-title":"MuscleJ2: A rebuilding of MuscleJ with new features for high-content analysis of skeletal muscle immunofluorescence slides","volume":"13","author":"Danckaert","year":"2023","journal-title":"Skelet Muscle"},{"key":"R19-20260302","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.toxrep.2019.07.011","article-title":"Hepatoprotective effects of silymarin on CCl(4)-induced hepatic damage in broiler chickens model","volume":"6","author":"Baradaran","year":"2019","journal-title":"Toxicol Rep"},{"key":"R20-20260302","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/vms3.641","article-title":"A review on the mechanisms of the effect of silymarin in milk thistle (Silybum marianum) on some laboratory animals","volume":"8","author":"Khazaei","year":"2022","journal-title":"Vet Med Sci"},{"key":"R21-20260302","doi-asserted-by":"crossref","first-page":"e0283806","DOI":"10.1371\/journal.pone.0283806","article-title":"CHAC1 inactivation is effective to preserve muscle glutathione but is insufficient to protect against muscle wasting in cachexia","volume":"18","author":"Li","year":"2023","journal-title":"PLoS One"},{"key":"R22-20260302","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/cne.22123","article-title":"Compartmentalization in the triceps brachii motoneuron nucleus and its relation to muscle architecture","volume":"516","author":"Lucas-Osma","year":"2009","journal-title":"J Comp Neurol"},{"key":"R23-20260302","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.3390\/antiox12091738","article-title":"Redox profile of skeletal muscles: Implications for research design and interpretation","volume":"12","author":"Vasileiadou","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"R24-20260302","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41467-020-20123-1","article-title":"Mechanisms of muscle atrophy and hypertrophy: Implications in health and disease","volume":"12","author":"Sartori","year":"2021","journal-title":"Nat Commun"},{"key":"R25-20260302","doi-asserted-by":"crossref","first-page":"e92048","DOI":"10.1371\/journal.pone.0092048","article-title":"Inflammation-induced acute phase response in skeletal muscle and critical illness myopathy","volume":"9","author":"Langhans","year":"2014","journal-title":"PLoS One"},{"key":"R26-20260302","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/jcsm.12620","article-title":"Muscular weakness and muscle wasting in the critically ill","volume":"11","author":"Schefold","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R27-20260302","doi-asserted-by":"crossref","first-page":"e60445","DOI":"10.7554\/eLife.60445","article-title":"Myogenin is an essential regulator of adult myofibre growth and muscle stem cell homeostasis","volume":"9","author":"Ganassi","year":"2020","journal-title":"Elife"},{"key":"R28-20260302","doi-asserted-by":"crossref","first-page":"C215","DOI":"10.1152\/ajpcell.00384.2021","article-title":"Ubiquitin E3 ligase Atrogin-1 protein is regulated via the rapamycin-sensitive mTOR-S6K1 signaling pathway in C2C12 muscle cells","volume":"323","author":"Nishimura","year":"2022","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_136_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:43:13Z","timestamp":1787773393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_136_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_136_25","relation":{},"ISSN":["0253-7613","1998-3751"],"issn-type":[{"value":"0253-7613","type":"print"},{"value":"1998-3751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"2025-02-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}